Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
5,601	62.26398	0	male	0	8	450	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	26,205	null	null	29	black	37.195313	65	0.567993	0.372986	1	1	no	0.8	0.6	no dnr	8	74	2.099609	132	36	38.79688	419	null	5.699219	0.699951	135	7.379883	77	14	1,750	0	0	no(M2 and SIP pres)	0
5,602	76.82996	0	male	0	25	449	ARF/MOSF w/Sepsis	ARF/MOSF	2	17	$25-$50k	9	120,051	null	null	24.5	white	21	34	0.642944	0.541992	33	0	yes	0.75	0.5	no dnr	25	130	15.099609	115	40	35	185.6875	2.899902	0.699951	1.099854	139	7.5	116	14	null	null	0	adl>=4 (>=5 if sur)	0
5,603	45.27899	1	male	1	7	7	Cirrhosis	COPD/CHF/Cirrhosis	5	12	under $11k	9	21,231	null	null	20.5	black	32.398438	55	0.600952	0.411987	2	0	no	0.4	0.88	dnr after sadm	6	72	9.898438	83	20	36.39844	319	null	null	0.799927	135	7.479492	102	18	500	null	6	<2 mo. follow-up	6
5,604	54.793	0	female	0	8	449	COPD	COPD/CHF/Cirrhosis	3	10	$25-$50k	0	11,367	null	null	9	white	20.398438	35	0.899902	0.831909	1	0	no	0.9	0.9	no dnr	8	71	6.899414	100	18	36.5	361.875	null	0.699951	0.799927	138	7.439453	86	8	2,400	null	null	SIP>=30	3.366699
5,605	58.61697	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	2	0	under $11k	0	39,128	null	null	22	white	24	34	0.779907	0.707886	9	0	no	0.8	0.3	dnr after sadm	4	53	6.799805	108	20	38	null	null	8.199219	0.699951	130	null	80	9	1,185	null	0	<2 mo. follow-up	0
5,606	46.26398	1	male	1	15	15	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	80,718	null	null	36.666657	other	38.796875	63	0.208984	0.113998	3	0	metastatic	0.6	0.6	dnr after sadm	11	73	7.799805	76	24	36.89844	242.84375	3	0.599976	0.699951	139	7.369141	227	14	null	null	0	<2 mo. follow-up	0
5,607	72.88696	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	122,871	null	null	50	white	51.695313	78	0.042	0.011999	11	0	no	0.2	0.1	dnr after sadm	10	138	14	105	29	38.69531	380	2.099609	0.199982	1.899902	155	7.469727	621	43	3,135	null	null	<2 mo. follow-up	1.925293
5,608	57.659	1	female	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	191,281	null	null	48.25	white	20.199219	26	0.842896	0.78894	6	1	no	0.96	0.94	dnr after sadm	12	65	6.899414	115	30	35	231.65625	3.399902	null	0.799927	131	7.439453	142	30	2,375	null	0	<2 mo. follow-up	0
5,609	66.72095	1	female	1	38	38	ARF/MOSF w/Sepsis	ARF/MOSF	1	4	$11-$25k	44	null	null	null	35.25	black	25.5	73	0.554932	0.441956	6	0	no	0.05	0.01	null	null	81	6.199219	72	20	37.79688	null	2.699707	3.399902	1.199951	130	null	104	15	null	null	0	<2 mo. follow-up	0
5,610	77.65094	0	male	0	25	447	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	null	0	90,077	null	null	28	white	29.898438	70	0.643921	0.543945	1	0	no	0.3	0.2	dnr after sadm	2	63	11.699219	110	44	37.69531	114.28125	3.799805	0.899902	0.699951	138	7.469727	129	32	2,125	null	0	no(M2 and SIP pres)	0
5,611	70.15997	0	male	0	23	446	Coma	Coma	0	null	under $11k	0	62,877	null	null	29.333328	black	16.597656	31	0.787964	0.746948	1	0	no	0.5	0.45	no dnr	23	52	20.796875	135	22	37.69531	110.90625	null	6.399414	2.799805	132	7.379883	50	96	126	null	0	adl>=4 (>=5 if sur)	0
5,612	37.51099	0	male	0	18	446	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	37	71,649	null	null	33.666657	white	26.097656	45	0.747925	0.668945	3	0	no	null	null	no dnr	18	105	8.798828	160	14	36.5	271.375	2.899902	0.5	0.599976	138	7.519531	171	14	930	null	null	null	2.772949
5,613	44.60199	1	male	0	6	15	Cirrhosis	COPD/CHF/Cirrhosis	4	10	under $11k	0	17,393	null	null	14	white	20.296875	35	0.859985	0.767944	1	0	no	0.75	0.65	no dnr	6	123	11.398438	125	20	36.89844	144.4375	2.399902	1.699951	2.399902	146	7.469727	240	28	3,670	6	5	<2 mo. follow-up	5
5,614	61.73297	0	female	0	11	446	CHF	COPD/CHF/Cirrhosis	2	9	null	9	39,205	null	null	34.5	other	37.898438	48	0.510986	0.309998	1	1	no	0.35	0.3	dnr after sadm	1	68	5.699219	74	28	36.29688	null	null	null	1.899902	138	null	79	41	1,000	null	0	no(M2 and SIP pres)	0
5,615	39.67697	0	male	0	11	446	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$25-$50k	44	35,968	null	null	29	black	26.699219	41	0.735962	0.652954	1	0	no	0.85	0.84	no dnr	11	79	5.5	80	20	36.59375	null	3.699707	null	0.799927	145	null	98	11	975	null	0	no(M2 and SIP pres)	0
5,616	75.30499	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	139,100	null	null	37	black	30.398438	63	0.45697	0.337952	17	0	yes	0.6	0.5	dnr after sadm	8	73	10.199219	76	24	38.69531	null	3.599609	0.299988	0.599976	134	null	85	8	3,100	null	5	<2 mo. follow-up	5
5,617	54.20898	0	male	0	9	445	CHF	COPD/CHF/Cirrhosis	3	16	$11-$25k	0	7,800	null	null	13	white	25.597656	41	0.830933	0.723999	1	1	no	0.8	0.7	no dnr	9	84	10.099609	76	22	35.29688	404.75	3.199707	1	1.5	134	7.489258	107	88	950	0	5	no(M2 and SIP pres)	5
5,618	41.87799	1	male	0	4	389	Lung Cancer	Cancer	1	14	$25-$50k	0	10,471	null	null	12	white	12	12	0.831909	0.633911	1	0	metastatic	0.9	0.7	no dnr	4	108	5.799805	125	6	36.39844	197.5	2.399902	7.299805	1.099854	145	7.359375	103	14	2,070	0	0	no(M2 and SIP pres)	0
5,619	44.10098	1	male	0	5	196	Lung Cancer	Cancer	1	12	under $11k	9	14,569	null	null	15	white	7.699219	12	0.859985	0.68689	1	0	metastatic	null	null	no dnr	5	28	41.09375	0	0	36.59375	88.5625	null	null	1.599854	149	7.379883	163	53	110	0	0	no(M2 and SIP pres)	0
5,620	56.50897	1	male	1	14	14	CHF	COPD/CHF/Cirrhosis	2	8	$11-$25k	0	34,959	null	null	19.333328	other	24.5	26	0.836914	0.73291	1	0	no	0.8	0.7	dnr after sadm	6	105	17.199219	125	24	39.5	266.625	null	0.599976	0.699951	131	7.489258	87	6	1,375	null	3	<2 mo. follow-up	3
5,621	81.85596	0	male	0	8	444	CHF	COPD/CHF/Cirrhosis	2	10	under $11k	0	5,708	null	null	8	white	20.199219	34	0.802979	0.681885	1	0	no	0.8	0.65	no dnr	8	165	10.199219	105	12	38.09375	147.5	2.299805	0.599976	0.899902	145	7.359375	160	21	4,500	null	0	no(M2 and SIP pres)	0
5,622	59.67999	1	male	0	18	146	Colon Cancer	Cancer	1	12	>$50k	0	23,874	null	null	9.666664	white	9	9	0.904907	0.780884	1	0	metastatic	0.8	0.5	no dnr	18	62	9.699219	75	32	36.19531	179.5625	3.199707	4	2	139	7.419922	137	47	88.1875	0	0	no(M2 and SIP pres)	0
5,623	51.504	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	$25-$50k	9	96,981	null	null	25	black	22.5	33	0.797974	0.731934	13	1	no	0.5	0.5	dnr after sadm	17	78	22.5	70	32	35.09375	190	2.899902	0.399963	0.799927	138	7.359375	208	12	1,920	null	0	<2 mo. follow-up	0
5,624	19.81899	0	male	0	18	442	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	0	37,577	null	null	23.666656	white	21.597656	35	0.928955	0.902954	1	0	no	0.9	0.9	no dnr	18	125	9.898438	125	11	39.19531	330	null	null	0.5	135	7.40918	184	7	1,865	0	0	no(M2 and SIP pres)	0
5,625	38.35699	0	male	0	14	442	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	null	0	28,330	null	null	14.333328	black	29.699219	46	0.802979	0.737915	2	0	no	0.8	0.8	no dnr	14	108	24.296875	75	12	38	230	1.799805	null	7.5	130	7.439453	330	73	90	0	0	null	0
5,626	81.24799	1	male	0	16	91	ARF/MOSF w/Sepsis	ARF/MOSF	2	5	$11-$25k	0	35,584	null	null	20	white	26.796875	51	0.586914	0.47699	3	0	yes	0.25	0.05	dnr after sadm	12	73	8.298828	100	22	36.5	null	null	null	2	133	null	88	34	null	null	6	adl>=4 (>=5 if sur)	6
5,627	81.45898	1	male	0	19	349	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	0	148,940	null	null	24.666656	white	23.898438	23	0.656982	0.557983	27	0	no	0.25	0.15	dnr after sadm	2	68	12.699219	82	20	36.29688	null	3.599609	0.599976	0.699951	151	null	89	12	1,000	null	7	adl>=4 (>=5 if sur)	7
5,628	49.52197	1	male	0	6	53	Lung Cancer	Cancer	1	12	>$50k	0	10,604	null	null	20	white	28	22	0.484985	0.165985	1	0	metastatic	0.9	0.6	dnr after sadm	4	112	9.199219	105	41	37.79688	161.21875	null	null	0.899902	140	7.449219	135	13	2,850	0	0	<2 mo. follow-up	0
5,629	19.127	0	female	0	4	439	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	17,649	null	null	18	white	23	19	0.921997	0.893921	1	0	no	0.95	0.95	no dnr	4	104	8.699219	112	20	37.5	null	3.099609	0.599976	0.899902	135	null	314	11	5,700	null	0	no(M2 and SIP pres)	0
5,630	79.41998	1	male	1	52	52	ARF/MOSF w/Sepsis	ARF/MOSF	3	13	null	9	134,458	null	null	31.75	white	19	38	0.806885	0.74292	1	0	no	0.7	0.65	dnr after sadm	48	107	11.599609	50	22	36.69531	155	null	null	0.899902	135	7.469727	103	23	2,625	null	6	<2 mo. follow-up	6
5,631	36.06799	1	male	0	32	142	ARF/MOSF w/Sepsis	ARF/MOSF	3	7	under $11k	0	73,203	null	null	19	black	20.398438	35	0.889893	0.850952	7	1	no	null	null	no dnr	32	52	36.898438	145	10	39.09375	167.5	null	null	1.5	139	7.399414	145	17	1,650	2	1	SIP>=30	1
5,632	69.66699	1	female	0	15	326	Colon Cancer	Cancer	1	11	$25-$50k	0	25,405	null	null	14.333328	white	13.798828	19	0.8479	0.664917	1	0	metastatic	0.9	0.75	no dnr	15	78	10.199219	65	16	36.19531	642.75	null	1.699951	1.099854	140	7.349609	158	10	2,950	null	1	null	1
5,633	34.42297	0	male	0	4	439	Cirrhosis	COPD/CHF/Cirrhosis	3	10	under $11k	9	3,491	null	null	8	black	26.5	35	0.810913	0.69397	1	0	no	0.5	0.3	no dnr	4	58	21.699219	115	10	38.59375	150	null	null	2.199707	139	7.489258	156	54	1,315	null	null	no(M2 and SIP pres)	2.38916
5,634	46.58698	1	female	0	45	365	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	>$50k	37	125,548	null	null	32.75	black	23.796875	40	0.75	0.671997	3	1	no	0.75	0.75	no dnr	45	113	null	55	30	36.5	null	null	null	null	140	null	420	null	4,005	null	0	adl>=4 (>=5 if sur)	0
5,635	50.57098	1	female	1	7	7	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	42,242	null	null	18	black	21	25	0.825928	0.715942	1	0	no	null	null	dnr after sadm	7	155	6.799805	105	30	36.39844	144.4375	null	null	1.299805	137	7.509766	267	26	1,460	4	4	<2 mo. follow-up	4
5,636	74.85797	1	female	0	41	52	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	44	51,726	null	null	20	white	23.796875	40	0.620972	0.515991	1	0	no	0.5	0.3	dnr after sadm	7	58	19.699219	115	56	38.59375	200	3.099609	36.195313	4.199219	137	7.40918	122	136	665	null	0	<2 mo. follow-up	0
5,637	68.71698	1	male	1	21	21	MOSF w/Malig	ARF/MOSF	1	7	null	0	84,442	null	null	29.333328	white	28.097656	35	0.599976	0.492981	1	0	yes	0.1	0.05	dnr after sadm	14	79	10.099609	68	20	37.69531	null	4	0.599976	0.899902	138	null	86	7	4,970	null	1	<2 mo. follow-up	1
5,638	66.54596	1	male	0	40	165	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	162,193	null	null	34.75	white	21.398438	26	0.796997	0.72998	7	0	no	null	null	no dnr	40	115	13.699219	135	32	38.59375	185.6875	null	null	0.599976	136	7.479492	185	9	950	null	0	no(M2 and SIP pres)	0
5,639	63.75098	0	female	0	33	437	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	0	106,855	null	null	28.75	white	23.398438	44	0.647949	0.547974	11	0	metastatic	0.7	0.5	no dnr	33	72	33.5	65	32	37.69531	116.3125	3	2.099609	0.899902	131	7.399414	98	15	3,475	null	1	adl>=4 (>=5 if sur)	1
5,640	57.487	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	null	0	78,351	null	null	32	white	37.398438	57	0.533936	0.418945	3	0	no	null	null	dnr after sadm	3	103	5.699219	64	28	36.5	340	null	0.5	0.699951	137	7.40918	133	14	550	null	0	<2 mo. follow-up	0
5,641	72.73596	0	female	0	40	436	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	26	145,725	null	null	31.25	black	26.5	65	0.602905	0.495972	3	0	no	null	null	no dnr	40	60	15.5	105	24	38.89844	170	2.599609	0.5	4.899414	141	7.389648	232	61	3,765	null	2	no(M2 and SIP pres)	2
5,642	57.29199	0	male	0	31	435	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	>$50k	0	121,247	null	null	22.5	white	26.699219	41	0.750977	0.671997	6	0	no	0.8	0.8	no dnr	31	122	0.099991	115	42	38.79688	135	null	1.699951	0.5	136	7.439453	232	12	5,620	null	0	adl>=4 (>=5 if sur)	0
5,643	70.73499	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	100	20,379	null	null	34	white	41	71	0.018997	0.004	1	0	no	0.1	0.05	dnr after sadm	3	75	5.299805	72	24	36.39844	null	2.5	5.799805	1	134	null	112	31	925	null	null	<2 mo. follow-up	3.334473
5,644	64.43799	0	male	0	52	434	CHF	COPD/CHF/Cirrhosis	2	null	null	0	165,091	null	null	13.75	white	12.199219	20	0.924927	0.871948	1	0	no	null	null	no dnr	52	107	10.798828	45	34	35.19531	115.29688	null	null	0.5	133	7.339844	131	20	1,730	null	null	null	2.231934
5,645	72.85699	1	male	0	14	225	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	under $11k	9	35,895	null	null	22	black	21.699219	37	0.740967	0.659912	1	1	yes	0.7	0.5	no dnr	14	81	8.599609	68	20	37.79688	null	null	0.599976	0.699951	138	null	116	4	null	1	null	null	1.166748
5,646	77.35797	0	female	0	10	433	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	9	87,387	null	null	27.5	white	18.597656	19	0.75293	0.674927	21	1	no	null	null	no dnr	10	122	null	140	12	36	205	null	null	1.199951	141	7.519531	103	32	165.5	null	null	null	2.695313
5,647	69.76599	1	female	0	3	101	Colon Cancer	Cancer	2	12	under $11k	0	11,018	null	null	9	white	17.199219	23	0.804932	0.583984	1	0	metastatic	null	null	no dnr	3	42	30.097656	155	8	35.89844	256.625	1.199951	2.5	4	133	7.279297	109	136	712	null	null	SIP>=30	1.869629
5,648	69.40497	1	male	0	13	388	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	28,535	null	null	23	white	26.597656	24	0.748901	0.603882	1	0	no	0.95	0.95	no dnr	13	75	11.398438	155	34	38.29688	240	1.199951	null	1.799805	142	7.459961	229	48	3,990	0	0	no(M2 and SIP pres)	0
5,649	49.45697	1	male	0	15	83	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	44	null	null	null	24	white	18.699219	41	0.762939	0.687988	17	0	no	0.6	0.5	null	null	72	19	45	34	38.09375	233.3125	2.799805	0.699951	0.699951	136	7.449219	94	39	1,375	null	0	adl>=4 (>=5 if sur)	0
5,650	51.82199	0	male	0	16	432	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	75,528	null	null	17	white	29.296875	36	0.738892	0.657959	4	0	no	0.6	0.5	no dnr	16	132	12.199219	125	32	36.19531	215	2.699707	4.399414	2.799805	145	7.479492	79	100	2,325	null	0	SIP>=30	0
5,651	82.65594	1	female	0	8	53	CHF	COPD/CHF/Cirrhosis	2	7	null	26	17,117	null	null	15.5	white	28.296875	30	0.533936	0.334961	1	0	no	0.7	0.5	dnr before sadm	-1	73	7.799805	105	22	35.79688	200	null	null	1.099854	141	7.369141	96	20	2,300	0	0	<2 mo. follow-up	0
5,652	50.06198	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	50,018	null	null	48	white	41.195313	106	0.522949	0.407959	1	0	no	0.3	0.15	dnr after sadm	3	72	6.199219	119	32	35.5	293.3125	null	null	1.099854	138	7.389648	69	29	2,525	null	0	<2 mo. follow-up	0
5,653	61.26199	0	male	0	18	431	Colon Cancer	Cancer	2	8	$25-$50k	0	37,422	null	null	18.666656	white	35.09375	27	0.429993	0.122986	1	1	metastatic	null	null	no dnr	18	48	13.699219	135	47	39.09375	148	null	0.599976	1.699951	147	7.389648	211	21	1,945	0	0	no(M2 and SIP pres)	0
5,654	50.20898	0	male	0	10	430	Colon Cancer	Cancer	1	14	$25-$50k	0	14,872	null	null	11.5	white	15.099609	6	0.863892	0.694946	1	0	metastatic	0.9	0.7	no dnr	10	38	18.097656	115	27	39	100	2	4.099609	2.5	148	7.349609	162	71	2,040	1	1	no(M2 and SIP pres)	1
5,655	45.76599	1	male	0	4	38	Lung Cancer	Cancer	2	12	null	0	5,333	null	null	13	white	43.195313	54	0.088989	0.003	1	1	metastatic	0.4	0.1	dnr after sadm	2	72	10.398438	75	8	39	120	2	0.699951	1.099854	140	7.399414	68	17	1,770	3	4	<2 mo. follow-up	4
5,656	70.34595	0	male	0	14	428	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	9	22,967	null	null	14.333328	white	24.5	45	0.754883	0.677979	1	0	no	0.75	0.75	no dnr	14	68	15.298828	115	30	38.39844	226.65625	1.799805	1.099854	6.799805	141	7.349609	77	71	5	null	0	no(M2 and SIP pres)	0
5,657	60.47897	0	female	0	9	428	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	11,988	null	null	13	white	22.398438	34	0.859985	0.768921	1	0	no	0.95	0.95	no dnr	9	55	5.799805	70	36	35.79688	203.3125	1.5	0.5	2.5	133	7.359375	139	50	2,760	2	0	SIP>=30	0
5,658	75.29395	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	1	16	>$50k	44	23,497	null	null	37	white	31.699219	43	0.133972	0.060997	4	0	metastatic	0.1	0	dnr after sadm	2	152	5.5	60	30	38.69531	228.5625	null	null	0.899902	134	7.439453	103	13	1,320	null	0	<2 mo. follow-up	0
5,659	65.396	1	male	0	25	38	COPD	COPD/CHF/Cirrhosis	5	null	null	9	78,471	null	null	26.25	white	31	34	0.662964	0.487976	1	1	no	0.7	0.6	dnr after sadm	16	108	9.699219	160	35	37.79688	165	null	null	0.699951	137	7.479492	130	17	3,775	null	null	<2 mo. follow-up	3.592773
5,660	69.08698	1	male	0	8	225	Lung Cancer	Cancer	1	14	null	0	13,090	null	null	13	white	16.097656	6	0.715942	0.436951	1	0	metastatic	0.7	0.3	no dnr	8	61	5	76	24	36.79688	null	2.5	1.699951	3	136	null	120	56	1,275	0	null	null	0.494751
5,661	59.61398	1	female	0	8	173	Colon Cancer	Cancer	1	15	>$50k	0	17,474	null	null	10	white	3	16	0.940918	0.859985	1	0	metastatic	0.9	0.8	no dnr	8	67	15.398438	105	28	35.89844	170	3.299805	null	4.599609	127	7.349609	200	101	3,355	0	null	null	0.494751
5,662	51.06897	0	male	0	50	424	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	0	153,904	null	null	33.25	hispanic	30	19	0.766968	0.692993	1	0	no	0.8	0.7	no dnr	50	112	15.5	115	50	39.09375	191.40625	null	0.899902	0.799927	141	7.449219	103	11	4,955	null	null	no(M2 and SIP pres)	2.137207
5,663	55.36798	1	male	0	12	226	Cirrhosis	COPD/CHF/Cirrhosis	1	1	under $11k	0	41,291	null	null	37	white	22.199219	29	0.783936	0.653931	1	0	no	0.6	0.6	no dnr	12	138	10	135	25	37.79688	167.5	null	null	6	136	7.399414	101	58	0	null	1	no(M2 and SIP pres)	1
5,664	68.646	0	female	0	8	423	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	14,600	null	null	6	white	19.796875	25	0.837891	0.782959	2	0	no	0.8	0.8	no dnr	8	67	9.298828	70	20	36.5	null	2.099609	1.399902	1.299805	132	null	59	40	4,450	1	null	no(M2 and SIP pres)	1.166748
5,665	72.71198	0	male	0	7	424	CHF	COPD/CHF/Cirrhosis	3	12	>$50k	0	10,007	null	null	9.5	white	23	36	0.797974	0.674927	1	0	no	0.95	0.75	no dnr	7	73	5.699219	96	20	36.29688	null	3.899902	0.5	0.799927	137	null	90	5	5,175	0	0	no(M2 and SIP pres)	0
5,666	67.50397	0	male	0	49	422	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	37	162,444	null	null	26	white	27.296875	61	0.5	0.381958	16	0	no	0.5	0.45	no dnr	49	79	5.799805	64	16	37	null	3.599609	0.799927	0.899902	137	null	90	11	4,725	null	0	SIP>=30	0
5,667	74.81696	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	44	22,608	null	null	31	white	22.699219	32	0.644897	0.543945	1	0	no	null	null	dnr after sadm	2	73	12.099609	119	22	35.79688	476	null	null	0.799927	132	7.479492	208	11	3,520	null	null	<2 mo. follow-up	2.480957
5,668	74.93195	1	male	1	42	42	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	$11-$25k	9	null	null	null	24	white	43.09375	46	0.247986	0.144989	1	0	no	0.4	0.2	null	null	77	5.799805	66	24	36.39844	null	null	2	1.699951	132	null	88	34	1,200	null	7	<2 mo. follow-up	7
5,669	40.24899	0	female	0	49	422	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	26	211,918	null	null	42.5	white	34.796875	69	0.629883	0.527954	1	0	no	0.4	0.3	no dnr	49	113	3.199707	72	22	37.69531	null	3.899902	1.299805	1.199951	136	null	112	13	3,600	null	0	no(M2 and SIP pres)	0
5,670	70.89697	1	male	1	20	20	Lung Cancer	Cancer	4	13	null	0	28,242	null	null	14.666664	white	30.597656	30	0.330994	0.064987	1	1	metastatic	0.4	0.4	dnr after sadm	12	108	14.5	104	32	35.79688	242.84375	null	1.299805	1	139	7.479492	112	37	3,900	null	0	<2 mo. follow-up	0
5,671	34.60098	0	female	0	56	421	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	227,914	null	null	41	black	27.699219	38	0.851929	0.800903	1	0	no	0.8	0.8	no dnr	56	62	8.298828	125	44	36.69531	280	2.599609	1.5	1.299805	138	7.419922	108	28	2,315	null	0	no(M2 and SIP pres)	0
5,672	81.71899	1	female	1	7	7	Coma	Coma	2	null	under $11k	44	26,992	null	null	30	black	23.5	30	0.250977	0.18399	1	1	yes	0.5	0.5	dnr after sadm	4	113	43.398438	125	29	38	187.5	2.5	1.399902	6.699219	139	7.329102	112	87	2,055	null	3	<2 mo. follow-up	3
5,673	66.43695	1	male	0	6	180	Lung Cancer	Cancer	2	null	null	0	12,589	null	null	15	white	14.099609	10	0.758911	0.504883	1	0	metastatic	0.7	0.5	no dnr	6	65	16.597656	105	36	38.89844	306.625	2	null	1.899902	160	7.459961	129	35	1,365	null	null	null	2.085938
5,674	55.754	0	male	0	24	420	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	>$50k	37	75,213	null	null	28.333328	white	33.59375	95	0.468994	0.349976	3	0	no	0.9	0.9	no dnr	24	57	6.099609	110	9	37.59375	175.5	null	null	0.899902	135	7.449219	142	16	2,645	null	0	no(M2 and SIP pres)	0
5,675	65.55194	1	male	0	32	63	Coma	Coma	1	12	null	94	65,156	null	null	25	white	21.699219	25	0.294983	0.224976	1	0	no	0.5	0.5	dnr after sadm	4	78	8.898438	118	34	36.89844	null	2.799805	0.799927	0.799927	139	null	91	4	2,700	null	0	null	0
5,676	68.84094	1	female	0	12	32	COPD	COPD/CHF/Cirrhosis	1	null	null	0	13,711	null	null	6.5	white	25.199219	26	0.775879	0.642944	1	0	no	null	null	dnr after sadm	1	72	5.5	115	14	37.09375	210	3.299805	0.699951	0.599976	136	7.379883	96	3	3,905	null	null	<2 mo. follow-up	3.021484
5,677	86.17395	1	male	1	4	4	Coma	Coma	0	null	null	100	7,012	null	null	8	white	19.296875	31	0.139984	0.089996	1	0	no	null	null	dnr after sadm	1	118	20.5	53	36	38.19531	236.65625	2.099609	0.399963	1	134	7.449219	92	31	1,540	null	null	<2 mo. follow-up	2.823731
5,678	50.61697	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	26	82,086	null	null	40	black	42.898438	80	0.212982	0.117996	22	0	no	null	null	dnr after sadm	4	115	17.199219	115	7	37.79688	213.3125	2	0.299988	1	133	7.439453	243	22	3,590	null	null	<2 mo. follow-up	2.580078
5,679	48.73099	0	female	0	11	418	Lung Cancer	Cancer	1	12	null	0	15,076	null	null	10.5	white	5.399414	12	0.890991	0.751953	1	0	metastatic	0.75	0.5	no dnr	11	79	4.099609	75	20	36.69531	null	null	0.599976	0.799927	139	null	212	8	1,100	0	0	no(M2 and SIP pres)	0
5,680	60.92499	0	female	0	44	418	Coma	Coma	0	12	under $11k	61	115,272	null	null	31.5	black	18.597656	28	0.553955	0.484985	3	0	no	0.05	0.05	no dnr	44	65	9.599609	72	12	36.19531	null	2.699707	17.597656	0.699951	136	null	95	11	null	null	0	adl>=4 (>=5 if sur)	0
5,681	80.51495	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	9	57,044	null	null	41	white	23.796875	45	0.657959	0.559937	8	1	no	0.3	0.2	dnr after sadm	2	125	6.899414	170	8	40.29688	438.0625	null	null	0.599976	134	7.479492	377	8	2,820	null	0	<2 mo. follow-up	0
5,682	49.54398	0	female	0	6	417	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	null	9	19,758	null	null	23	black	21	14	0.85791	0.80896	2	0	no	0.8	0.75	no dnr	6	75	8.298828	68	20	37	null	2	4.899414	0.899902	129	null	112	12	null	0	0	SIP>=30	0
5,683	68.44098	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	2	17	>$50k	44	22,156	null	null	46	white	28	40	0.322998	0.208984	4	0	yes	0.05	0.05	dnr after sadm	2	73	18.898438	78	12	36.59375	276.625	null	1	6.799805	131	7.459961	139	107	1,005	null	7	<2 mo. follow-up	7
5,684	65.47797	1	male	1	4	4	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	4,656	null	null	9	white	29.398438	32	0.668945	0.495972	1	0	yes	0.6	0.4	no dnr	4	70	8.798828	110	16	36.39844	217.5	2.899902	null	4.5	130	7.419922	74	113	2,510	6	4	<2 mo. follow-up	4
5,685	73.04297	1	female	0	12	263	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	under $11k	0	29,016	null	null	25.5	black	24.398438	59	0.772949	0.699951	1	1	no	0.2	0.2	no dnr	12	142	5.799805	115	28	38.59375	227.5	2.699707	null	0.699951	138	7.429688	121	18	2,360	null	0	adl>=4 (>=5 if sur)	0
5,686	77.08698	1	male	0	19	65	CHF	COPD/CHF/Cirrhosis	2	null	null	0	39,533	null	null	26.333328	white	25.5	32	0.737915	0.588989	1	0	no	null	null	no dnr	19	60	10.699219	115	5	36.79688	251.40625	1	null	1.099854	136	7.369141	141	7	3,352	null	null	null	2.953613
5,687	45.64499	0	male	0	7	415	Lung Cancer	Cancer	1	23	$25-$50k	0	7,302	null	null	6.5	white	21.097656	10	0.669922	0.370972	1	0	metastatic	0.6	0.3	no dnr	7	48	22.398438	175	28	39.89844	130	null	null	0.899902	142	7.359375	178	18	1,710	0	null	no(M2 and SIP pres)	0.494751
5,688	50.02597	0	male	0	20	415	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	41	66,125	null	null	22	white	33.796875	70	0.185974	0.096985	1	0	metastatic	null	null	no dnr	20	108	15	70	4	36.09375	320	null	null	7.5	137	7.399414	121	47	0	0	0	no(M2 and SIP pres)	0
5,689	78.72095	1	male	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	$11-$25k	41	112,577	null	null	32.75	black	34	56	0.237	0.135986	1	0	yes	0.2	0.1	dnr after sadm	4	105	13.298828	120	13	39.29688	193.3125	2.399902	1.799805	0.799927	133	7.449219	105	20	3,700	null	0	<2 mo. follow-up	0
5,690	55.38898	1	male	1	79	79	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	$11-$25k	0	292,373	null	null	41.75	white	31.5	57	0.669922	0.573975	5	0	no	null	null	dnr after sadm	17	49	5.5	0	0	39.29688	177	2.899902	0.5	1.199951	147	7.549805	312	28	4,065	null	0	adl>=4 (>=5 if sur)	0
5,691	63.24399	1	female	0	11	66	Coma	Coma	2	10	null	0	13,705	null	null	13	white	23.199219	27	0.651978	0.592896	1	0	yes	0.2	0.05	dnr before sadm	-1	77	15.099609	84	20	36.09375	null	4.299805	0.699951	1.299805	142	null	92	26	1,125	null	1	adl>=4 (>=5 if sur)	1
5,692	95.53699	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	61	11,729	null	null	26	white	35.796875	66	0.088989	0.034996	1	0	no	0.5	0.5	no dnr	4	107	71.6875	45	13	36.59375	251.84375	3.399902	0.599976	1.199951	138	7.40918	79	23	2,470	null	0	<2 mo. follow-up	0
5,693	27.25299	0	female	0	38	412	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	37	161,518	null	null	37	white	31.898438	47	0.652954	0.553955	7	0	no	0.6	0.2	no dnr	38	115	14	105	24	37.79688	340	2.699707	null	0.799927	136	7.469727	189	25	1,935	null	0	no(M2 and SIP pres)	0
5,694	53.728	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	1	11	under $11k	37	33,447	null	null	36	black	27.699219	62	0.30896	0.196991	4	0	metastatic	0.3	0.15	dnr after sadm	2	103	8.699219	55	12	36.59375	null	null	0.299988	0.899902	141	null	128	14	850	null	1	<2 mo. follow-up	1
5,695	50.73199	1	male	0	4	185	Lung Cancer	Cancer	1	14	$25-$50k	0	5,207	null	null	11	white	18.296875	20	0.715942	0.436951	1	0	metastatic	0.75	0.6	no dnr	4	115	8.199219	115	12	36.79688	142.5	3.299805	null	1.099854	135	7.359375	111	18	2,080	0	0	no(M2 and SIP pres)	0
5,696	44.89798	0	male	0	12	411	Colon Cancer	Cancer	1	12	null	0	33,648	null	null	24	black	49.796875	36	0.097992	0.003	1	0	metastatic	null	null	no dnr	12	108	17.5	60	32	36.29688	286.625	1.899902	0.599976	1	140	7.459961	120	21	1,180	0	0	no(M2 and SIP pres)	0
5,697	39.90997	0	male	0	6	411	Colon Cancer	Cancer	1	12	$11-$25k	0	8,356	null	null	12	black	6.099609	10	0.938965	0.85498	1	0	metastatic	0.8	0.6	no dnr	6	127	5.899414	120	10	38.5	157.5	1.899902	1.5	0.699951	127	7.459961	99	10	5,565	0	null	no(M2 and SIP pres)	0.494751
5,698	66.80896	1	male	1	11	11	Lung Cancer	Cancer	2	12	under $11k	9	9,857	null	null	11.5	white	24.398438	47	0.483948	0.164978	1	1	metastatic	0.2	0.05	dnr after sadm	3	72	6.799805	75	32	35.29688	287.75	2.699707	0.399963	1.299805	126	7.419922	96	49	2,555	null	0	<2 mo. follow-up	0
5,699	40.129	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	98,253	null	null	45	black	41.5	71	0.552979	0.439941	2	0	no	0.5	0.5	dnr after sadm	14	42	22	155	37	34.69531	234.28125	1.399902	1.699951	1.399902	144	7.199219	57	27	1,260	null	0	<2 mo. follow-up	0
5,700	40.24899	0	male	0	6	410	Colon Cancer	Cancer	1	16	>$50k	0	11,127	null	null	14	white	11	6	0.909912	0.791992	1	0	metastatic	0.9	0.8	no dnr	6	130	6.399414	75	8	35	428.5625	2.099609	0.799927	0.699951	134	7.469727	244	7	null	0	null	null	0.494751

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.